FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032552232> ?p ?o ?g. }

• W2032552232 endingPage "276" @default.
• W2032552232 startingPage "267" @default.
• W2032552232 abstract "Heme oxygenase (HO)-catalyzed degradation of cellular heme moieties generates biliverdin and equimolar amounts of carbon monoxide (CO), which has been implicated as a possible modulator of neural function. Technical difficulties preclude direct measurements of CO within intact nervous tissues; hence, alternative procedures are needed to monitor the formation and possible biologic functions of this gas. In the present study rat hypothalamic explants were found to generate 114 +/- 5 or 127 +/- 11 pmol biliverdin/hypothalamus/1 h (n = 3) upon incubation with 1 or 10 microM hemin, respectively. Ten micromolar zinc-protoporphyrin IX (Zn-PP-IX), a known inhibitor of HO, significantly decreased the degradation of 10 microM hemin from 127 +/- 11 to 26 +/- 11 pmol biliverdin/hypothalamus/1 h (n = 3; P < 0.01). Biliverdin was the principal product of HO-dependent heme degradation, as its possible conversion into bilirubin was precluded by hemin-dependent inhibition of biliverdin reductase. Basal or hemin-supplemented hypothalamic incubations were also shown to generate sizable amounts of propentdyopents (PDPs), reflecting HO-independent degradation pathways which do not liberate CO and cannot be inhibited by Zn-PP-IX. Plotting the ratio of biliverdin to PDPs thus provided an index of the efficiency with which hemin was degraded through biochemical pathways involving CO. Under the experimental conditions of our study, the biliverdin/PDPs ratio varied from 0 to 32 or 15%, depending on the absence or presence of 1 or 10 microM hemin respectively: this suggested that the formation of CO was most efficient at 1 microM hemin. Under these defined conditions, 1 microM hemin was also found to inhibit the release of arginine vasopressin (AVP) evoked by depolarizing solutions of KCl. A series of experiments showed that the effect of hemin was counteracted by Zn-PP-IX, and also by tin-mesoporphyrin IX, which is even more selective in inhibiting HO; it was also attenuated in the presence of the gaseous scavenger ferrous hemoglobin. Furthermore, the inhibition of AVP release could be reproduced by omitting hemin and by incubating hypothalami under CO, whereas treatment with biliverdin had no effect. This suggested that the release of AVP was suppressed by HO degradation of hemin, yielding CO as a modulator of hypothalamic function. These observations may be relevant to diseases characterized by inappropriate secretion of AVP and enzymatic disturbances affecting the synthesis of heme and the formation of CO through the HO pathway (e.g., acute intermittent porphyria or lead intoxication)." @default.
• W2032552232 created "2016-06-24" @default.
• W2032552232 creator A5001166788 @default.
• W2032552232 creator A5036083199 @default.
• W2032552232 creator A5046249111 @default.
• W2032552232 creator A5046455340 @default.
• W2032552232 creator A5046852415 @default.
• W2032552232 creator A5049569770 @default.
• W2032552232 creator A5055398953 @default.
• W2032552232 date "1997-10-01" @default.
• W2032552232 modified "2023-10-02" @default.
• W2032552232 title "Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkage between heme catabolism and neuroendocrine function" @default.
• W2032552232 cites W1497013369 @default.
• W2032552232 cites W1501532586 @default.
• W2032552232 cites W1529716765 @default.
• W2032552232 cites W1529948332 @default.
• W2032552232 cites W1583903788 @default.
• W2032552232 cites W1586487499 @default.
• W2032552232 cites W1948313709 @default.
• W2032552232 cites W1981165639 @default.
• W2032552232 cites W1994780702 @default.
• W2032552232 cites W1995789604 @default.
• W2032552232 cites W1998084962 @default.
• W2032552232 cites W2011795894 @default.
• W2032552232 cites W2021569785 @default.
• W2032552232 cites W2028297219 @default.
• W2032552232 cites W2029666029 @default.
• W2032552232 cites W2039903290 @default.
• W2032552232 cites W2046111903 @default.
• W2032552232 cites W2054802842 @default.
• W2032552232 cites W2054924599 @default.
• W2032552232 cites W2070147796 @default.
• W2032552232 cites W2072170860 @default.
• W2032552232 cites W2075977089 @default.
• W2032552232 cites W2078356295 @default.
• W2032552232 cites W2081141077 @default.
• W2032552232 cites W2084300208 @default.
• W2032552232 cites W2087173548 @default.
• W2032552232 cites W4231834629 @default.
• W2032552232 cites W4237621925 @default.
• W2032552232 cites W4242490895 @default.
• W2032552232 cites W95614001 @default.
• W2032552232 doi "https://doi.org/10.1016/s0169-328x(97)00197-6" @default.
• W2032552232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9406943" @default.
• W2032552232 hasPublicationYear "1997" @default.
• W2032552232 type Work @default.
• W2032552232 sameAs 2032552232 @default.
• W2032552232 citedByCount "52" @default.
• W2032552232 countsByYear W20325522322013 @default.
• W2032552232 countsByYear W20325522322014 @default.
• W2032552232 countsByYear W20325522322015 @default.
• W2032552232 countsByYear W20325522322016 @default.
• W2032552232 countsByYear W20325522322017 @default.
• W2032552232 countsByYear W20325522322018 @default.
• W2032552232 countsByYear W20325522322019 @default.
• W2032552232 countsByYear W20325522322020 @default.
• W2032552232 countsByYear W20325522322023 @default.
• W2032552232 crossrefType "journal-article" @default.
• W2032552232 hasAuthorship W2032552232A5001166788 @default.
• W2032552232 hasAuthorship W2032552232A5036083199 @default.
• W2032552232 hasAuthorship W2032552232A5046249111 @default.
• W2032552232 hasAuthorship W2032552232A5046455340 @default.
• W2032552232 hasAuthorship W2032552232A5046852415 @default.
• W2032552232 hasAuthorship W2032552232A5049569770 @default.
• W2032552232 hasAuthorship W2032552232A5055398953 @default.
• W2032552232 hasConcept C134018914 @default.
• W2032552232 hasConcept C161790260 @default.
• W2032552232 hasConcept C181199279 @default.
• W2032552232 hasConcept C185592680 @default.
• W2032552232 hasConcept C23849879 @default.
• W2032552232 hasConcept C2776217839 @default.
• W2032552232 hasConcept C2776253728 @default.
• W2032552232 hasConcept C2777513400 @default.
• W2032552232 hasConcept C2777723881 @default.
• W2032552232 hasConcept C2779219270 @default.
• W2032552232 hasConcept C512735826 @default.
• W2032552232 hasConcept C55493867 @default.
• W2032552232 hasConcept C86803240 @default.
• W2032552232 hasConceptScore W2032552232C134018914 @default.
• W2032552232 hasConceptScore W2032552232C161790260 @default.
• W2032552232 hasConceptScore W2032552232C181199279 @default.
• W2032552232 hasConceptScore W2032552232C185592680 @default.
• W2032552232 hasConceptScore W2032552232C23849879 @default.
• W2032552232 hasConceptScore W2032552232C2776217839 @default.
• W2032552232 hasConceptScore W2032552232C2776253728 @default.
• W2032552232 hasConceptScore W2032552232C2777513400 @default.
• W2032552232 hasConceptScore W2032552232C2777723881 @default.
• W2032552232 hasConceptScore W2032552232C2779219270 @default.
• W2032552232 hasConceptScore W2032552232C512735826 @default.
• W2032552232 hasConceptScore W2032552232C55493867 @default.
• W2032552232 hasConceptScore W2032552232C86803240 @default.
• W2032552232 hasIssue "1-2" @default.
• W2032552232 hasLocation W20325522321 @default.
• W2032552232 hasLocation W20325522322 @default.
• W2032552232 hasOpenAccess W2032552232 @default.
• W2032552232 hasPrimaryLocation W20325522321 @default.
• W2032552232 hasRelatedWork W144984646 @default.
• W2032552232 hasRelatedWork W1555594482 @default.

• next